Addus HomeCare Corporation (ADUS) Earnings
Addus HomeCare Corporation is expected to report next earnings on August 3, 2026 (in NaN days), with a consensus EPS estimate of $1.69. ADUS has beaten EPS estimates in 10 of its last 12 reported quarters (average surprise +5.9% over the last four).
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| May 5, 2026 | $1.52 | $1.62 | +6.6% | $364M | -0.8% |
| Feb 23, 2026 | $1.71 | $1.61 | -5.8% | $373M | +0.1% |
| Feb 26, 2024 | $1.17 | $1.32 | +12.8% | $276M | -0.8% |
| May 1, 2023 | $0.88 | $0.97 | +10.2% | $252M | -1.3% |
| Feb 27, 2023 | $0.95 | $1.11 | +16.8% | $247M | +0.4% |
| Oct 31, 2022 | $0.93 | $0.94 | +1.1% | $240M | -0.7% |
| May 2, 2022 | $0.76 | $0.77 | +1.3% | $227M | -0.3% |
| Feb 24, 2022 | $0.92 | $0.97 | +5.4% | $225M | -0.7% |
| May 3, 2021 | $0.74 | $0.74 | +0.0% | $205M | +0.0% |
| Feb 25, 2021 | $0.75 | $0.82 | +9.3% | $196M | +10.3% |
| Nov 2, 2020 | $0.65 | $0.76 | +16.9% | $194M | +16.9% |
| May 4, 2020 | $0.64 | $0.77 | +20.3% | $190M | +28.6% |
Source: company filings + earnings calendar. For informational purposes only — not investment advice.
Earnings call summary
Q1 FY2026 · May 5, 2026
AI summary of management’s prepared remarks and analyst Q&A. For informational purposes only — not investment advice.
Management highlights
- Total revenue up 7.7% y-o-y to $363.6M, adjusted EPS up 14.1% to $1.62, adjusted EBITDA up 9.7% to $44.5M. - Impact of weather event in late Jan led to ~$1.5M revenue loss but Feb and Mar normalized. - Closed acquisition of HomeCourt HomeCare's personal care ops in Fort Wayne, IN, with another Indiana acquisition expected. - Illinois rate increase added ~$17.5M annualized revenue. - New Mexico legislature allocated $10M for home and community-based services. - Positive hiring trends in personal care, hospice census growth, home health operating income improvement. - Focus on expanding via acquisitions in new markets with scale and ability to expand services.
Guidance
- Anticipate adjusted EBITDA margin above 12% for full year 2026. - Expect to maintain disciplined capital allocation strategy, manage net leverage ratio, focus on enhancing shareholder value. - Second Indiana acquisition expected to close later this year subject to regulatory approvals. - Home health expected to see positive momentum with final home health rule 2026 being more favorable than proposed, with potential for growth as they evaluate opportunities to further strategy.
Segment performance
Total revenue for Q1 2026 was $363.6 million, up 7.7% y-o-y. Personal care segment: revenues $281.1 million (77.3% of total), same-store revenue growth 6.5%, same-store hours up 2.2% y-o-y. Hospice care: revenues $65.8 million (18.1% of total), same-store revenue up 7.7% y-o-y, average daily census 3,804 (up 8.2% y-o-y). Home health: revenues $16.7 million (4.6% of total), same-store revenue down y-o-y but operating income improved vs prior year.
Risks & headwinds
- Weather events can impact revenue as seen with ~$1.5M loss in Q1 due to storms. - Regulatory approvals needed for acquisitions could delay or affect the process. - Uncertainty around future rate increases in home health care. - Potential impact of fraud, waste, and abuse initiatives on smaller competitors and how it may affect the industry and Addis, though Addis believes its compliance efforts position it well.
Analyst Q&A
Q: About caregiver app rollout in Texas, progress and benefits?
A: Deployed in three largest states, good momentum in Texas with over 10% of caregivers adopting, helps increase service percentage and engage caregivers.
Q: On hospice cap risk?
A: No cap concerns currently as referral mix and patient base are well managed.
Q: Update on state budgets, especially Indiana?
A: Indiana has nice support, two acquisitions give good coverage, Illinois budget not finalized yet, New Mexico has dollars allocated for home and community-based services.
Q: Home health payer mix trend?
A: Slight impact from rate updates in Q1, likely to revert to historical norms.
Q: Personal care census comments?
A: Slight sequential decline due to weather, but Illinois saw growth and March census exceeded Jan/Feb.
Q: Self-directed care model impact?
A: Self-directed care has compliance issues, Addis' agency model with compliance processes benefits.
Q: Home health rate backdrop for 2027?
A: Hopeful for positive rate due to potential change in CMS perspective on fraud, waste, abuse and reimbursement.
Q: Addis' exposure to self-directed personal care?
A: Little impact in most states as Addis focuses on states with agency care understanding.
Q: M&A pipeline size?
A: Seeing larger M&A opportunities of size similar to Gentiva, balance sheet strength allows quick pursuit.
Q: Indiana market share and attractiveness?
A: Good footprint, decent rates, less competition, and managed Medicaid component attractive.
Q: Labor availability impact?
A: Seeing positive hiring trends, wage inflation and candidate flow in right direction.
Q: SG&A leverage and caregiver app?
A: Caregiver app not major impact on SG&A, ongoing leverage from revenue growth.
Q: Home health admission trends?
A: Saw positive trends in Q1, focus on volume, bridge program in New Mexico, Tennessee, and starting in Illinois.
Q: Personal care same store hours growth and outlook?
A: Target 2%-2.5% growth, feel good about trajectory.
Q: Stock comp related to former president COO retirement?
A: Accelerated vesting due to retirement was one-time impact, not a run rate.